Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy [clinicaltrials:NCT00120861]
Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy [clinicaltrials:NCT00120861]
Bio2RDF identifier
NCT00120861
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00120861
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
This study is being con ...... hepatitis C viral infection.
brief title [clinicaltrials_vocabulary:brief-title]
Valopicitabine Alone and Toget ...... to Respond to Standard Therapy
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-07-11T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Genotype-1
Previously failed treatment
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2010-06-09T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00120861
official title [clinicaltrials_vocabulary:official-title]
A Randomized, Phase IIb Clinic ...... to Respond to Standard Therapy
org study id [clinicaltrials_vocabulary:org-study-id]
NV-08A-004
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2005-01-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2010-06-01T00:00:00Z
identifier
clinicaltrials:NCT00120861
title
Valopicitabine Alone and Toget ...... to Respond to Standard Therapy
@en
type
label
Valopicitabine Alone and Toget ...... y [clinicaltrials:NCT00120861]
@en